1-9 of 9
Keichiro Mihara, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T Cells Bearing Anti-CD19- and/or Anti-CD38-Chimeric Antigen Receptors Effectively Abrogate Primary Double-Hit Lymphoma Cells

Keichiro Mihara, MD PhD, Tetsumi Yoshida, MD, Yoshifumi Takei, MD PhD, Naomi Sasaki, MD PhD, Yoshihiro Takihara, MD PhD, Tatsuo Ichinohe, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4182.
https://doi.org/10.1182/blood.V128.22.4182.4182
Published: 2016
Journal Articles

All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors

Keichiro Mihara, MD PhD, Tetsumi Yoshida, MD, Seiko Ishida, MD PhD, Yoshifumi Takei, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD PhD, Kazuhiro Morishita, MD PhD, Yoshihiro Takihara, MD PhD, Tatsuo Ichinohe, MD
Journal: Blood
Blood (2015) 126 (23): 591.
https://doi.org/10.1182/blood.V126.23.591.591
Published: 2015
Journal Articles

Adult T-Cell Leukemia/Lymphoma Cells Were Eliminated By T Cells With Anti-CD38 Chimeric Antigen Receptor Through CD38 Expression Induced By All-Trans Retinoic Acid

Tetsumi Yoshida, MD, Keichiro Mihara, MD, PhD, Akira Kitanaka, MD, PhD, Kazuya Shimoda, MD, PhD, Kazuhiro Morishita, MD, PhD, Yoshihiro Takihara, MD, PhD, Tatsuo Ichinohe, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1824.
https://doi.org/10.1182/blood.V122.21.1824.1824
Published: 2013
Journal Articles

All-Trans Retinoic Acid Enhances the Cytotoxic Effect of T Cells with Anti-CD38 Chimeric Receptor in Acute Myeloid Leukemia

Keichiro Mihara, MD, PhD, Joyeeta Bhattacharyya, MD, PhD, Yoshihiro Takihara, MD, PhD, Akiro Kimura, MD
Journal: Blood
Blood (2012) 120 (21): 1901.
https://doi.org/10.1182/blood.V120.21.1901.1901
Published: 2012
Journal Articles

T-Cell Immunotherapy with a Chimeric Receptor Against CD38 Is Effective in Eliminating Myeloma Cells

Keichiro Mihara, MD, PhD, Joyeeta Bhattacharyya, MD, PhD, Akira Kitanaka, MD, PhD, Akihiro Ihara, MD, PhD, Akira Sakai, MD, PhD, Yoshiaki Kuroda, MD, PhD, Hideki Asaoku, MD, Yoshihiro Takihara, MD, PhD, Akiro Kimura, MD
Journal: Blood
Blood (2011) 118 (21): 885.
https://doi.org/10.1182/blood.V118.21.885.885
Published: 2011
Journal Articles

B-Cell Lymphoma Cells Overexpressing BMI-1 Are Correlated with Drug Resistance through Enhanced Expression of Survivin and Are Effectively Eliminated by T Cells with Anti-CD38 Chimeric Receptor

Joyeeta Bhattacharyya, Keichiro Mihara, MD, PhD, Motoaki Ohtsubo, Shin'ichiro Yasunaga, MD, PhD, Yoshihiro Takihara, MD, PhD, Masaharu Hoshi, Akiro Kimura, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3613.
https://doi.org/10.1182/blood.V116.21.3613.3613
Published: 2010
Journal Articles

Synergistic and Persistent Effect of T-Cell Immunotherapy with Anti-CD19 or Anti-CD38 Chimeric Receptor on B-Cell Lymphoma in Conjunction with Rituximab

Keichiro Mihara, MD, PhD, Kazuyoshi Yanagihara, PhD, Misato Takigahira, PhD, Yoshihiro Takihara, MD, PhD, Akiro Kimura, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2610.
https://doi.org/10.1182/blood.V112.11.2610.2610
Published: 2008
Journal Articles

Activated T Cell-Mediated Immunotherapy with a Chimeric Receptor Against CD38 in B-Cell Malignancies.

Keichiro Mihara, MD, PhD, Kazuyoshi Yanagihara, Ph.D, Misato Takigahira, Takahiro Ochiya, Ph.D, Chihaya Imai, M.D., Ph.D, Akira Kitanaka, M.D., Ph.D, Yoshihiro Takihara, M.D., Ph.D, Akiro Kimura, M.D., Ph.D
Journal: Blood
Blood (2007) 110 (11): 2356.
https://doi.org/10.1182/blood.V110.11.2356.2356
Published: 2007
Journal Articles

Mesenchymal Cells Determine the Response of Acute Lymphoblastic Leukemia Cells to L-Asparaginase.

Shotaro Iwamoto, MD, Keichiro Mihara, MD, PhD, James R. Downing, MD, Ching-Hon Pui, MD, Dario Campana, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 833.
https://doi.org/10.1182/blood.V108.11.833.833
Published: 2006